STOCKWATCH
·
Pharmaceuticals
USFDA8 Feb 2025, 05:34 pm

TYCHE INDUSTRIES LTD. Receives Warning Letter from USFDA for its Kakinada Facility

AI Summary

TYCHE INDUSTRIES LTD. has received a warning letter from the USFDA for its manufacturing facility situated at Kakinada, Andhra Pradesh, following the Official Action Indicated (OAI) status received in January 2025. The company is committed to working closely with the USFDA to address the issues and respond within the stipulated timelines. Quality and compliance are of utmost importance to the company, and it remains committed to adhering to CGMP quality standards across its facilities.

Key Highlights

  • TYCHE INDUSTRIES LTD. receives warning letter from USFDA
  • Facility in Kakinada, Andhra Pradesh is affected
  • Company committed to working closely with USFDA
  • Issues to be addressed within stipulated timelines
  • Company emphasizes quality and compliance
TYCHE
Pharmaceuticals
TYCHE INDUSTRIES LTD.

Price Impact